GO:1905370 serine-type endopeptidase complex: Components, Assembly and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1905370 (serine-type endopeptidase complex) is a cellular component defined as a protein complex capable of serine-type endopeptidase activity.
The term captures multimeric assemblies whose catalytic serine residue mediates peptide-bond cleavage, including viral and host protease complexes.
The hepatitis C virus NS3-NS4A complex is a textbook example: NS4A acts as a cofactor that stabilizes and activates the NS3 serine protease for polyprotein maturation.
Serine-type endopeptidase complexes are also found in fungal pathogens and in reproductive and immune-related proteomes, where they contribute to virulence and tissue remodeling.
Loss-of-function studies of conserved serine protease components, such as mitochondrial CLPP, reveal organism-specific phenotypes and stress responses.
CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of complex assembly, catalysis, and substrate specificity.

Description

GO:1905370, serine-type endopeptidase complex, is a Gene Ontology cellular component term that describes any protein complex whose molecular function is serine-type endopeptidase activity. In practical terms, it refers to multimeric assemblies in which a catalytic serine residue within a protease domain cleaves peptide bonds in target proteins. This term is essential for annotating proteolytic machines that function as obligate complexes rather than as isolated enzymes, and it helps researchers distinguish complex-dependent proteolysis from that carried out by monomeric serine proteases. The hepatitis C virus (HCV) NS3-NS4A complex is a well-characterized example: NS3 provides the serine protease domain, while NS4A acts as a cofactor that intercalates into the NS3 structure to stabilize the active site and enhance polyprotein processing. Because such complexes are central to viral maturation and host-pathogen interactions, they are high-value targets for antiviral and mechanistic studies. Beyond virology, serine-type endopeptidase complexes have been detected in multidrug-resistant fungal pathogens, where they may contribute to virulence and host tissue invasion. Proteomic surveys of equine follicular fluid have also identified secreted serine-type peptidases, suggesting roles in reproductive physiology and extracellular matrix remodeling. In the context of COVID-19-related anosmia, receptors and proteolytic processing events involving serine proteases have been implicated in viral entry and sensory dysfunction. Conserved mitochondrial serine proteases, such as CLPP, form complexes whose loss leads to distinct phenotypes across organisms, underscoring the evolutionary and functional diversity of this GO term. Together, these examples illustrate why GO:1905370 is a critical annotation for understanding proteolytic pathways in health and disease.

serine-type endopeptidase complex At A Glance

GO ID GO:1905370
GO term serine-type endopeptidase complex
Ontology cellular_component
Synonym None listed in QuickGO
Definition A protein complex which is capable of serine-type endopeptidase activity.
Major function Catalysis of peptide-bond hydrolysis by a serine residue within a multimeric assembly
Example complex Hepatitis C virus NS3-NS4A serine protease complex
Related activity Serine-type endopeptidase activity (GO:0004252)
Taxonomic scope Found in viruses, fungi, plants, and animals

What Is GO:1905370?

According to the Gene Ontology, GO:1905370 (serine-type endopeptidase complex) is a protein complex which is capable of serine-type endopeptidase activity. This means the complex as a whole, or at least one subunit within it, uses a catalytic serine residue to hydrolyze peptide bonds in substrate proteins. The term is classified under the cellular_component ontology aspect, indicating that it describes a physical assembly of proteins rather than a standalone enzymatic activity or a biological process. It is distinct from terms that describe individual serine proteases because it requires the formation of a multimeric complex for function. The definition does not specify subunit composition, stoichiometry, or subcellular localization, so annotations can include viral protease-cofactor complexes, mitochondrial proteolytic machines, and secreted fungal peptidase assemblies, provided they exhibit serine-type endopeptidase activity as a complex.

Why Is serine-type endopeptidase complex Important in Cell Biology?

GO:1905370 is important because it provides a standardized way to annotate proteolytic complexes that are essential for viral maturation, host immune evasion, mitochondrial quality control, and tissue remodeling. Many serine-type endopeptidase complexes are validated drug targets, as exemplified by HCV NS3-NS4A inhibitors, and they serve as models for understanding how cofactor binding and complex assembly regulate catalytic activity. The term also facilitates comparative genomics and proteomics by grouping diverse complexes under a shared functional definition, enabling researchers to identify conserved and organism-specific proteolytic machines.
Provides a precise GO annotation for multimeric serine proteases, distinguishing them from monomeric enzymes.
HCV NS3-NS4A complex is a paradigm for cofactor-dependent activation of a viral serine protease.
Serine-type endopeptidase complexes are implicated in viral polyprotein maturation and are targets for antiviral therapy.
Fungal pathogens in the Candida haemulonii complex produce serine-type peptidases that may contribute to multidrug resistance and virulence.
Secreted serine-type peptidases in follicular fluid suggest roles in reproductive tissue remodeling.
Proteolytic processing by serine proteases has been linked to COVID-19-related anosmia through receptor and entry mechanisms.
Mitochondrial CLPP complexes illustrate conserved roles in protein quality control and stress responses.
The term supports functional enrichment analysis in proteomics and transcriptomics studies.
CRISPR-based models enable causal testing of complex subunits in disease phenotypes.
Understanding complex assembly can guide development of allosteric inhibitors that disrupt protein-protein interfaces.

What Happens During serine-type endopeptidase complex?

Complex Assembly and Cofactor Binding
In simple terms: Proteins come together to form a working protease machine, often with a helper protein that turns it on.
The formation of a serine-type endopeptidase complex typically requires the association of a catalytic subunit with one or more cofactor proteins. In HCV, the NS3 serine protease domain binds to NS4A, a small cofactor that intercalates into the NS3 structure and stabilizes the active site, which is essential for efficient polyprotein processing. This assembly step is often rate-limiting and can be regulated by cellular factors. The complex is then competent to cleave specific peptide bonds in substrate polyproteins or host proteins.
Substrate Recognition and Catalysis
In simple terms: The complex grabs a target protein and cuts it at a specific spot using a serine residue.
Once assembled, the serine-type endopeptidase complex recognizes substrate sequences through extended binding pockets. The catalytic mechanism involves a charge-relay system in which the serine hydroxyl attacks the peptide carbonyl, forming a tetrahedral intermediate and acyl-enzyme complex. For HCV NS3-NS4A, cleavage occurs at multiple junctions in the viral polyprotein, releasing mature nonstructural proteins required for replication. Substrate specificity is determined by the S1-S4 pockets and can be modulated by cofactor interactions.
Polyprotein Maturation and Downstream Effects
In simple terms: Cutting the viral protein chain into pieces allows the virus to build its replication machinery.
In HCV, the NS3-NS4A complex processes the viral polyprotein at the NS3/4A, NS4A/4B, NS4B/5A, and NS5A/5B junctions, which is a prerequisite for assembly of the viral replicase complex. Inhibition of this complex blocks viral replication, validating it as a drug target. Similar processing events may occur in other systems, such as fungal secreted peptidases that cleave host proteins during infection.
Regulation by Cellular and Environmental Cues
In simple terms: The cell can turn the protease complex on or off depending on stress or infection.
The activity and abundance of serine-type endopeptidase complexes can be regulated at multiple levels, including cofactor availability, post-translational modifications, and subcellular localization. For example, mitochondrial CLPP complex function is influenced by cellular stress and developmental stage, with loss-of-function leading to distinct phenotypes in plants and other organisms. In reproductive tissues, secreted serine-type peptidases in follicular fluid may be regulated by hormonal cycles and local proteolytic networks. Viral complexes such as NS3-NS4A are also subject to host immune pressures and can be targeted by interferon-induced effectors.

Key Genes Involved in GO:1905370 serine-type endopeptidase complex

The following genes and proteins represent subunits, cofactors, and regulatory components associated with serine-type endopeptidase complexes across viral, fungal, and host systems.
GeneMajor RoleResearch Relevance
HCV NS3Catalytic serine protease subunit of the NS3-NS4A complexModel for cofactor-dependent activation and antiviral targeting
HCV NS4ACofactor that stabilizes and activates NS3 proteaseEssential for complex assembly and polyprotein processing
HCV NS4BMembrane-associated component of the replication complexDownstream substrate of NS3-NS4A cleavage
HCV NS5APhosphoprotein involved in replication and assemblyCleavage product of NS3-NS4A processing
HCV NS5BRNA-dependent RNA polymeraseReleased by NS3-NS4A cleavage for replicase assembly
Candida haemulonii secreted peptidasesSerine-type peptidases in multidrug-resistant pathogensPotential virulence factors and drug resistance markers
Equine follicular fluid serine peptidasesSecreted proteases in reproductive fluidBiomarkers of follicle development and remodeling
CLPPMitochondrial serine protease forming a complexConserved roles in protein quality control and stress
APOC1Apocarrier protein linked to tumor immune infiltrationContextual marker in esophageal squamous cell carcinoma
TMPRSS2Host serine protease involved in viral entryImplicated in COVID-19-related anosmia mechanisms
ACE2Receptor for SARS-CoV-2Interacts with proteolytic processing in anosmia
FurinHost serine protease that cleaves viral spike proteinRelevant to COVID-19 pathogenesis
Neuropilin-1Host receptor facilitating viral entryAssociated with olfactory dysfunction
Cathepsin LCysteine protease that can compensate for serine proteasesAlternative entry pathway in COVID-19
HtrA2/OmiMitochondrial serine proteaseQuality control and apoptosis regulation
Lon proteaseMitochondrial serine protease complexConserved stress response
ClpP in plantsMitochondrial protease complex subunitLoss-of-function phenotypes in plants

How Is serine-type endopeptidase complex Regulated?

The assembly and activity of serine-type endopeptidase complexes are regulated by cofactor availability, post-translational modifications, and cellular stress pathways. In HCV, NS4A binding is required for NS3 protease stability and function, and this interaction can be modulated by host factors. Mitochondrial CLPP complex activity is influenced by developmental and stress signals, with loss of function leading to distinct phenotypes across organisms. In reproductive tissues, secreted serine-type peptidases in follicular fluid may be regulated by hormonal cycles and local proteolytic networks. Viral complexes can also be targeted by interferon-induced effectors, linking regulation to innate immunity.

serine-type endopeptidase complex and Human Disease

GeneDisease / BiologyPotential Experimental Model
HCV NS3-NS4AHepatitis C virus infectionHuh-7 cell line with subgenomic replicon; CRISPR KO of NS3
Candida haemulonii peptidasesMultidrug-resistant fungal infectionCandida haemulonii clinical isolates; CRISPR KO of peptidase genes
TMPRSS2COVID-19-related anosmiaHuman olfactory epithelial cells; TMPRSS2 KO iPSCs
CLPPMitochondrial proteostasis and stressCLPP knockout mouse models; plant CLPP mutants
APOC1Esophageal squamous cell carcinomaKYSE cell lines; APOC1 overexpression and KO
Hepatitis C Virus Infection
The HCV NS3-NS4A serine-type endopeptidase complex is essential for viral polyprotein maturation and replication. Mutations that disrupt complex formation or catalytic activity block viral propagation, and the complex is the target of direct-acting antiviral drugs. Research on this complex has provided fundamental insights into cofactor-dependent protease activation and substrate specificity.
Fungal Pathogenesis and Multidrug Resistance
Multidrug-resistant emergent pathogens in the Candida haemulonii complex produce cell-associated and secreted serine-type peptidases. These enzymes may contribute to host tissue invasion, immune evasion, and resistance to antifungal agents. Studying these complexes could reveal new targets for antifungal therapy.
COVID-19-Related Anosmia
SARS-CoV-2 entry and subsequent olfactory dysfunction involve host serine proteases such as TMPRSS2 and furin, which process the viral spike protein. Receptors including ACE2 and neuropilin-1 facilitate entry, and proteolytic events are thought to contribute to anosmia pathophysiology. Serine-type endopeptidase complexes may therefore be relevant to sensory deficits in COVID-19.
Mitochondrial Proteostasis and Disease
Mitochondrial serine protease complexes such as CLPP are critical for protein quality control. Loss of conserved CLPP function leads to different phenotypes in plants and other organisms, highlighting its role in stress responses and potential links to mitochondrial disease.

From serine-type endopeptidase complex-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of the catalytic subunit abolish complex activity?CRISPR knockout of NS3 or CLPP in relevant cell lines
Does a point mutation in the catalytic serine affect substrate cleavage?CRISPR point mutation (S>A) knock-in at the catalytic residue
Does cofactor binding regulate complex stability?Knock-in of tagged NS4A for affinity purification and proteomics
Does overexpression of the complex drive viral replication?Overexpression of NS3-NS4A in hepatoma cells
Can a candidate gene rescue complex formation?Knock-in of wild-type or mutant cDNA into KO background
What are the downstream substrates of the complex?CRISPR KO followed by quantitative proteomics

How to Study the serine-type endopeptidase complex Process

MethodWhat It MeasuresTypical Application
Affinity purification-mass spectrometryProtein-protein interactions and complex compositionIdentifying NS3-NS4A interacting partners
Activity-based probesActive serine protease complexesProfiling secreted peptidases in Candida
Fluorogenic peptide assaysKinetic parameters of peptide cleavageInhibitor screening for HCV protease
CRISPR knockout screensHost genes required for complex functionIdentifying COVID-19 entry factors
Cryo-EMHigh-resolution structure of complexVisualizing NS3-NS4A active site
Proteomics of follicular fluidSecreted serine-type peptidasesReproductive biology studies
Mitochondrial functional assaysCLPP complex activity and stress responsePlant and mammalian CLPP studies
ImmunofluorescenceSubcellular localization of complex subunitsMitochondrial CLPP imaging
Proteomic Identification of Complex Components
Affinity purification coupled with mass spectrometry (AP-MS) can identify subunits and interacting partners of serine-type endopeptidase complexes. For example, tagging NS4A and purifying the NS3-NS4A complex from HCV-infected cells reveals cofactor-dependent interactions. Similar approaches can be applied to fungal secreted peptidases and mitochondrial CLPP complexes.
Activity-Based Probes and Enzymatic Assays
Fluorogenic peptide substrates and activity-based probes can measure serine-type endopeptidase activity in complex preparations. These assays are useful for determining kinetic parameters and for screening inhibitors of HCV NS3-NS4A. They can also detect secreted peptidases in fungal cultures and follicular fluid.
CRISPR Screening for Complex Regulators
Genome-wide CRISPR knockout screens can identify host genes required for the assembly or function of serine-type endopeptidase complexes. Such screens have been used to uncover host factors involved in viral entry and proteolytic processing, including TMPRSS2 and furin in COVID-19. Libraries targeting protease families can reveal synthetic lethal interactions.
Structural and Imaging Approaches
Cryo-EM and X-ray crystallography provide high-resolution structures of serine-type endopeptidase complexes, revealing cofactor binding interfaces and catalytic site geometry. Fluorescence microscopy with tagged subunits can visualize subcellular localization and complex assembly in live cells, as demonstrated for mitochondrial CLPP.

How CRISPR Can Be Used to Study GO:1905370 serine-type endopeptidase complex

Knockout

CRISPR knockout of genes encoding subunits of serine-type endopeptidase complexes, such as HCV NS3 or mitochondrial CLPP, can abolish complex formation and catalytic activity. This approach is used to test whether a candidate gene is essential for viral replication or mitochondrial proteostasis. Knockout cell lines also serve as negative controls for rescue experiments.

Point Mutation

Introducing point mutations in the catalytic serine residue or in cofactor-binding interfaces can dissect the contribution of individual residues to complex activity. For example, mutating the catalytic serine of NS3 to alanine abolishes protease activity without affecting complex assembly, allowing separation of assembly and catalysis. Similar strategies can be applied to CLPP and fungal peptidases.

Knock-in

Knock-in of tagged versions of complex subunits, such as NS4A with a FLAG or HA tag, enables affinity purification and live-cell imaging. This approach is valuable for identifying dynamic interactions and subcellular localization of serine-type endopeptidase complexes. Knock-in of disease-associated mutations can also model human phenotypes.

Overexpression

Overexpression of complex subunits, such as NS3-NS4A in hepatoma cells, can enhance viral polyprotein processing and replication, providing a gain-of-function system to study complex-driven phenotypes. Overexpression of host serine proteases like TMPRSS2 can also increase viral entry in cell models of COVID-19.

How EDITGENE Supports serine-type endopeptidase complex Research

Researchers studying serine-type endopeptidase complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, substrate cleavage, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes associated with GO:1905370.
Contact EDITGENE today to design your custom CRISPR model for serine-type endopeptidase complex research.

Frequently Asked Questions About serine-type endopeptidase complex

GO:1905370 is a Gene Ontology cellular component term defined as a protein complex which is capable of serine-type endopeptidase activity. It describes multimeric assemblies that cleave peptide bonds using a catalytic serine residue.
Genes include HCV NS3 and NS4A, which form a viral protease complex, as well as host genes such as TMPRSS2, furin, and mitochondrial CLPP. Fungal pathogens also express serine-type peptidases.
The complex catalyzes the hydrolysis of peptide bonds in substrate proteins, often as part of viral polyprotein maturation, host protein processing, or mitochondrial quality control.
Regulation occurs through cofactor binding, post-translational modifications, subcellular localization, and cellular stress signals. For example, NS4A binding is required for NS3 protease activity.
Hepatitis C virus infection, COVID-19-related anosmia, fungal infections caused by Candida haemulonii, and mitochondrial proteostasis disorders have been linked to these complexes.
It is a serine-type endopeptidase complex in which NS3 provides the catalytic protease domain and NS4A acts as an essential cofactor for stability and activity.
CRISPR knockout, point mutation, knock-in, and overexpression can be used to test the role of individual subunits in complex assembly, catalysis, and disease phenotypes.
Common methods include affinity purification-mass spectrometry, activity-based probes, fluorogenic peptide assays, CRISPR screens, cryo-EM, and immunofluorescence.
Yes, the HCV NS3-NS4A complex is a validated target for direct-acting antivirals, and other complexes are being explored for antifungal and antiviral therapies.
A serine protease is a single enzyme, whereas a serine-type endopeptidase complex is a multimeric assembly that may require cofactors for activity, as defined by GO:1905370.

Conclusion

GO:1905370 (serine-type endopeptidase complex) provides a precise annotation for multimeric proteolytic machines that use a catalytic serine to cleave peptide bonds. From the well-studied HCV NS3-NS4A complex to fungal secreted peptidases and mitochondrial CLPP, these complexes play critical roles in viral maturation, host-pathogen interactions, and cellular proteostasis. Understanding their assembly, regulation, and substrate specificity is essential for developing targeted therapies and for interpreting functional genomics data. CRISPR-based models, combined with proteomics and structural biology, offer powerful tools to dissect the molecular mechanisms of serine-type endopeptidase complexes in health and disease.

References

  1. 1. Bartenschlager R et al.. 1995. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation.. J Virol 69(12):7519-28 PMID: 7494258
  2. 2. Souto XM et al.. 2019. Identification of cell-associated and secreted serine-type peptidases in multidrug-resistant emergent pathogens belonging to the Candida haemulonii complex.. Folia Microbiol (Praha) 64(2):245-255 PMID: 30259351
  3. 3. Ishak GM et al.. 2022. Follicular-fluid proteomics during equine follicle development.. Mol Reprod Dev 89(7):298-311 PMID: 35762042
  4. 4. Al-Saigh NN et al.. 2024. Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects.. Int J Mol Sci 25(15) PMID: 39126095
  5. 5. Lohmann V et al.. 1996. Processing pathways of the hepatitis C virus proteins.. J Hepatol 24(2 Suppl):11-9 PMID: 8836884
  6. 6. Bartenschlager R. 1997. Candidate targets for hepatitis C virus-specific antiviral therapy.. Intervirology 40(5-6):378-93 PMID: 9675642
  7. 7. Cao X et al.. 2023. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.. Pathol Oncol Res 29:1610976 PMID: 36969562
  8. 8. Huang S et al.. 2020. Loss of conserved mitochondrial CLPP and its functions lead to different phenotypes in plants and other organisms.. Plant Signal Behav 15(12):1831789 PMID: 33073672
Contact Us
*
*
*
*
How did you hear about us: